SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 7.16 |
| Enterprise Value ($M) | 6.10 |
| Book Value ($M) | 2.83 |
| Book Value / Share | 0.47 |
| Price / Book | 2.53 |
| NCAV ($M) | 1.30 |
| NCAV / Share | 0.22 |
| Price / NCAV | 5.49 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.00 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -5.38 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.96 |
| Current Ratio | 1.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.22 |
| Assets | 8.75 |
| Liabilities | 5.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 4.84 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,255 | 58,644 | 26.01 | |
| 3,814 | 49,770 | 7.66 | |
| 23,839 | 85,065 | 28.02 | |
| 17,897 | 94,658 | 18.91 | |
| 82,525 | 269,297 | 30.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APTO – Aptose Biosciences Inc. | APVO – Aptevo Therapeutics Inc. |
| ARTL – Artelo Biosciences, Inc. | ASRT – Assertio Holdings, Inc. |
| ATNF – 180 Life Sciences Corp. |
Financial data and stock pages provided by
Fintel.io